scholarly journals In vitro studies of alcohol-induced liver injury in virally-infected human hepatocytes: Advantages and limitations

Author(s):  
Natalia A. Osna ◽  
Srivatsan Kidambi
2020 ◽  
Vol 36 (1) ◽  
Author(s):  
Chise Tateno ◽  
Yuha Kojima

AbstractWe have succeeded in stable mass production of chimeric PXB-mice, whose liver is repopulated by human hepatocytes at a ratio of more than 70%, and we are providing these mice to academia and pharmaceutical companies to support the development of new drugs or studies of liver function. Furthermore, we isolated human hepatocytes, called PXB-cells, from the chimeric mice, and provide them for clients weekly for in vitro studies. In this review, we summarize the existing characterizations of PXB-mice and PXB-cells and their present and future applications.


Bioprinting ◽  
2021 ◽  
pp. 119-137
Author(s):  
Kenneth Douglas

Abstract: This chapter reports on efforts to bioprint liver tissue, including the important types of liver cells and also the liver’s cytoarchitecture—the typical pattern of cellular arrangement within liver tissue. The chapter gives an account of the liver’s remarkable regenerative ability, its over 500 vital functions, its unusual blood supply, and the difficulty of growing liver cells in vitro (in the laboratory). The chapter includes a description of a hybrid printing/casting method employing human hepatocytes (liver cells) encapsulated in a hydrogel called a “liver tissue seed.” Implanted into mice with a liver injury, the seed tissue provided functional support to the failing liver and expanded in size by 50-fold over the course of 11 weeks. The chapter also mentions Organovo, the first commercial bioprinting company and a pioneer in bioprinting commercially available human tissues, notably their lead product, liver tissue.


2021 ◽  
Vol 12 (11) ◽  
Author(s):  
Masatoshi Kakizaki ◽  
Yuichiro Yamamoto ◽  
Shunya Nakayama ◽  
Kazuaki Kameda ◽  
Etsuko Nagashima ◽  
...  

AbstractAcute liver injury (ALI) induced by chemicals or viruses can progress rapidly to acute liver failure (ALF), often resulting in death of patients without liver transplantation. Since liver transplantation is limited due to a paucity of donors, expensive surgical costs, and severe immune rejection, novel therapies are required to treat liver injury. Extracellular vesicles (EVs) are used for cellular communication, carrying RNAs, proteins, and lipids and delivering them intercellularly after being endocytosed by target cells. Recently, it was reported that EVs secreted from human hepatocytes have an ability to modulate the immune responses; however, these roles of EVs secreted from human hepatocytes were studied only with in vitro experiments. In the present study, we evidenced that EVs secreted from human hepatocytes attenuated the CCL4-induced ALI by inhibiting the recruitment of monocytes through downregulation of chemokine receptor in the bone marrow and recruitment of neutrophils through the reduction of C-X-C motif chemokine ligand 1 (CXCL1) and CXCL2 expression levels in the liver.


2006 ◽  
Vol 15 (04) ◽  
pp. 245-257 ◽  
Author(s):  
H. J. Rolf ◽  
K. G. Wiese ◽  
H. Siggelkow ◽  
H. Schliephake ◽  
G. A. Bubernik

Sign in / Sign up

Export Citation Format

Share Document